No abstract available
MeSH terms
-
Apolipoprotein B-48 / blood
-
Apolipoprotein C-III / blood
-
Biomarkers / blood
-
Blood Glucose / drug effects
-
Blood Glucose / metabolism
-
Cholesterol / blood
-
Diabetes Mellitus, Type 2 / blood
-
Diabetes Mellitus, Type 2 / drug therapy*
-
Dietary Fats / administration & dosage
-
Dietary Fats / metabolism
-
Exenatide
-
Fatty Acids, Nonesterified / blood
-
Glucagon-Like Peptide-1 Receptor
-
Humans
-
Hyperlipidemias / blood
-
Hyperlipidemias / prevention & control*
-
Hypoglycemic Agents / administration & dosage
-
Hypoglycemic Agents / therapeutic use*
-
Injections, Subcutaneous
-
Insulin / blood
-
Lipoproteins / blood
-
Peptides / administration & dosage
-
Peptides / therapeutic use*
-
Postprandial Period
-
Receptors, Glucagon / agonists*
-
Time Factors
-
Treatment Outcome
-
Triglycerides / blood
-
Venoms / administration & dosage
-
Venoms / therapeutic use*
Substances
-
Apolipoprotein B-48
-
Apolipoprotein C-III
-
Biomarkers
-
Blood Glucose
-
Dietary Fats
-
Fatty Acids, Nonesterified
-
GLP1R protein, human
-
Glucagon-Like Peptide-1 Receptor
-
Hypoglycemic Agents
-
Insulin
-
Lipoproteins
-
Peptides
-
Receptors, Glucagon
-
Triglycerides
-
Venoms
-
remnant-like particle cholesterol
-
Cholesterol
-
Exenatide